Donor Utilization in the Recent Era: Effect of Sex, Drugs, and Increased Risk.

Authors:
Baran DA; Long A; Lansinger J; Copeland JG; Copeland H.

Journal:
Circ Heart Fail

Publication Year: 2022

DOI:
10.1161/CIRCHEARTFAILURE.122.009547

PMCID:
PMC9287105

PMID:
35726629

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Heart Fail

Abbreviation: Circ Heart Fail

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure Wi…
Azzo JD; Dib MJ; Zagkos L and 21 more (2024) - Transparency Score: 3/6
Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction.
Tamargo M; Martínez-Legazpi P; Espinosa MÁ and 16 more (2023) - Transparency Score: 3/6
Propensity-Matched Study of Early Cardiac Rehabilitation in Patients With Acute Decompensated Heart…
Enzan N; Matsushima S; Kaku H and 8 more (2023) - Transparency Score: 3/6
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Va…
Butt JH; Ibrahim W; Dewan P and 10 more (2023) - Transparency Score: 4/6
Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1.
Fudim M; Yazdi D; Egolum U and 10 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Baran has consulted for Livanova, Getinge, Abiomed, and Abbott. He is on the Steering Committee for Procyrion and CareDx. He is a speaker for Pfizer. Dr J.G. Copeland has consulted for Syncardia. Dr H. Copeland has received consulting fees from Bridge to Life. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025